Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumab

In conclusion, the 10 mg/kg IV dose was considered appropriate in all patients and there was no evidence to suggest a hig her response would be achieved by increasing the dose.
Source: Journal of Pharmacokinetics and Pharmacodynamics - Category: Drugs & Pharmacology Source Type: research